Official ESCRS | European Society of Cataract & Refractive Surgeons
Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Posters

Search Title by author or title

Phaco ExPRESS versus phaco trabeculectomy in the treatment of OAG in cataract patients

Poster Details

First Author: M.Yilmazli TURKEY

Co Author(s):    A. Ustuner   A. Asici                 

Abstract Details

Purpose:

To compare the efficacy, safety and see the results and complications of Phacoemulsification with Trabeculectomy (P-Trab) versus Phacoemulsifacation with Ex-Press implantation surgery (P-Ex-Press) in patients with open angle glaucoma(OAG) that could not be controlled with maximal-tolerated anti glaucoma medications(or had drug allergy). The trabeculectomy is the gold standard procedure used in the treatment of glaucoma, although its complication profile is quite broad. Ex-Press device was introduced as an alternative to trabeculectomy.

Setting:

Patients from the Glaucoma Department of the �Ä�°stanbul Eye Hospital at �Ä�°stanbul, Turkey were included for this study.

Methods:

A total of 41-eyes diagnosed OAG and cataract underwent P-Ex-Press or P-Trab surgery.20 eyes were treated with P-Ex-Press and 21-eyes were treated with P-Trab(p>0.05).Mean age of the patients was 69-in both groups(p>0.05).22 female and 19 male patients were included(p>0.05).Both procedures involved the creation of a scleral flap.Than phacoemultification was performed.After an incision made with a needle,the Ex-Press device was implanted .In the second group,a sclerostomy and peripheral iridectomy were done.Cases were followed for 12 months.The main outcome measures were:mean intraocular pressure(IOP), IOP reduction,the reduction in glaucoma medications,the change of visual acuity and the incidence of postoperative complications.

Results:

IOP in the-P-ExPress group went from-34,6-to-15,0(decreased by 43%).In the-P-Trab group,it went from-33,2-to-14,5(decreased by 43,7%)(p<0.05).The average number of anti glaucoma medications in the-P-Ex-Press group went from 2.5-to-0.6;in theP-Trab group it went from-2.7-to-0.9 a year after surgery(p>0.05).Visual Acuity(VA)in the P-Ex-Press group improved from-0.25-to-0.54.VA in the P-Trab group improved from 0,24-to-0.51(p> 0.05).The most frequent complication were shallow anterior chamber (1and 4-cases in-P-Express versus P-Trab)and 1-hyphema in P-Trab group.In the P-Ex-PRESS group there was 1-case of bleb needling and 1-case of bleb revision.In the P-Trab group,2-eyes required bleb revision,1-eye required re-suturing,and 1-eye required repeat surgery for uncontrolled IOP with maximal-tolerated anti glaucoma medication.

Conclusions:

Both groups demonstrated significant IOPdecreases from baseline and had significant decreases in the mean number of IOP-lowering medications.Visual acuity at 12 months was improved in the majority of patients in both groups.The P-Ex-Press had a lower rate of postoperative complication and postoperative interventions required. Use of the Ex-Press device led to faster visual recovery because of less tissue damage.Ex-Press implantation is associated with higher surgical cost due to the cost of the device itself. The P-Press is one of the alternatives to P-Trab,equals in its efectiveness and is noted for less tissue traumatization and lower complications.

Financial Disclosure:

NONE

Back to Poster listing